Ardelyx (ARDX) EBT Margin (2013 - 2026)

Ardelyx (ARDX) reported EBT Margin of 39.8% for Q1 2026, up 1456.0% on a YoY basis from 2.56% in Q1 2025, and down 12357.81% quarter-over-quarter from 0.32% in Q4 2025.

Ardelyx (ARDX) EBT Margin (2013 - 2026) Analysis & Trends

Ardelyx has reported EBT Margin for 12 years, with the latest figure at 39.8% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin rose 1456.0% year-over-year to 39.8%; the trailing twelve-month figure through Mar 2026 stood at 18.06% (down 348.0% YoY), and the FY2025 full-year result was 14.89%, down 323.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 39.8%, down from 0.32% in the prior quarter.
  • The five-year high for EBT Margin was 24.21% in Q4 2022, with the low at 5997.65% in Q1 2022.
  • Historically, EBT Margin has averaged 476.33% across 5 years, with a median of 39.8% in 2026.
  • Annual changes were most pronounced in 2022 — EBT Margin tumbled 549394 bps — and 2023, when it soared 576228 bps.
  • Ardelyx's EBT Margin stood at 24.21% in 2022, then sank by 442 bps to 82.85% in 2023, then soared by 105 bps to 4.03% in 2024, then tumbled by 108 bps to 0.32% in 2025, then tumbled by 12358 bps to 39.8% in 2026.
  • The last three EBT Margin figures came in at 39.8% (Q1 2026), 0.32% (Q4 2025), and 25.5% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn -39.80%

Historic Data

Download Data
DateValue
Mar 31, 2026 -39.80%
Dec 31, 2025 -0.32%
Sep 30, 2025 -25.50%
Jun 30, 2025 -19.53%
Mar 31, 2025 -54.36%
Dec 31, 2024 4.03%
Sep 30, 2024 -0.78%
Jun 30, 2024 -22.38%
Mar 31, 2024 -57.36%
Dec 31, 2023 -82.85%
Sep 30, 2023 12.11%
Jun 30, 2023 -76.66%
Mar 31, 2023 -235.37%
Dec 31, 2022 24.21%
Sep 30, 2022 -459.15%
Jun 30, 2022 -1,066.19%
Mar 31, 2022 -5,997.65%
Dec 31, 2021 -3,521.28%
Sep 30, 2021 -3,715.77%
Jun 30, 2021 -3,441.51%